Browse Category

Investment Analysis News 25 December 2025

Novo Nordisk Stock (NVO): Wegovy Pill FDA Approval, CagriSema Filing, and the 2026 Outlook Investors Are Watching (Dec. 25, 2025)

Novo Nordisk Stock (NVO): Wegovy Pill FDA Approval, CagriSema Filing, and the 2026 Outlook Investors Are Watching (Dec. 25, 2025)

December 25, 2025 — Christmas Day is a market holiday in the U.S., but Novo Nordisk A/S is still doing what it’s done for most of the past two years: pulling attention (and capital) toward anything labeled GLP‑1. NASDAQ Trader The headline catalyst is straightforward and extremely investable: the U.S. FDA has approved Novo Nordisk’s Wegovy pill, making it the first oral GLP‑1 treatment approved for chronic weight management in adults with obesity (or overweight with comorbidities). Reuters But the stock story is bigger than a single approval. Heading into 2026, Novo’s equity narrative is being rewritten around three questions:
Alphabet (GOOG) Stock After the Bell on Dec. 25, 2025: Latest News, Fresh Forecasts, and What to Watch Before the Market Reopens Dec. 26

Alphabet (GOOG) Stock After the Bell on Dec. 25, 2025: Latest News, Fresh Forecasts, and What to Watch Before the Market Reopens Dec. 26

Dec. 25, 2025 (Christmas Day) — If you’re looking at Alphabet Inc. (Google) Class C shares (NASDAQ: GOOG) “after the bell” today, the first thing to know is simple: there was no U.S. stock-market bell on Dec. 25. Nasdaq and the NYSE were closed for Christmas, following an early close on Wednesday, Dec. 24. NASDAQ Trader That makes tonight’s “after-hours” story less about price swings and more about positioning: what investors learned from the latest headlines, what analysts are saying heading into year-end, and which risks could matter most when trading resumes Friday, Dec. 26, 2025. Where Alphabet (GOOG) stock
Nvidia (NVDA) Stock After Hours Today, Dec. 25, 2025: Groq Licensing Deal, CES 2026 Spotlight, and What to Watch Before the Market Opens Dec. 26

Nvidia (NVDA) Stock After Hours Today, Dec. 25, 2025: Groq Licensing Deal, CES 2026 Spotlight, and What to Watch Before the Market Opens Dec. 26

December 25, 2025 — After-hours recap and pre-market preview NVIDIA Corporation (NASDAQ: NVDA) enters the final stretch of 2025 with investors digesting a major strategic headline—a non-exclusive AI inference technology licensing agreement with chip start-up Groq and the departure of Groq’s top leaders to Nvidia—while U.S. equities sit closed for Christmas Day. That holiday pause matters: there was no regular closing bell on Thursday, Dec. 25, meaning the most recent “after-hours” read is tied to Wednesday’s early-close Christmas Eve session. NASDAQ Trader With normal trading set to resume Friday, Dec. 26, tomorrow’s open is the first real chance for full
Pfizer (PFE) Stock News, Forecasts and Analyst Outlook as of Dec. 25, 2025

Pfizer (PFE) Stock News, Forecasts and Analyst Outlook as of Dec. 25, 2025

Pfizer Inc. (NYSE: PFE) heads into Christmas Day with investors digesting a dense run of December headlines: a 2026 outlook that came in below Wall Street expectations, ongoing restructuring and cost-cutting, fresh U.S. drug-pricing initiatives that could reshape the industry’s economics, and multiple pipeline updates spanning oncology, immunology and cardiometabolic disease. U.S. markets are closed on Thursday, Dec. 25, 2025, but Pfizer shares last traded on Wednesday, Dec. 24 at $25.03, after moving between $24.90 and $25.14 intraday, according to the latest available pricing data. Below is a detailed look at the current news, forward guidance, and sell-side forecasts shaping
Intel Stock (INTC) News, Forecasts, and Analyst Outlook for Dec. 25, 2025: Nvidia’s 18A Pause, a U.S. Government Stake, and What Comes Next

Intel Stock (INTC) News, Forecasts, and Analyst Outlook for Dec. 25, 2025: Nvidia’s 18A Pause, a U.S. Government Stake, and What Comes Next

December 25, 2025 — Intel Corporation (NASDAQ: INTC) heads into the Christmas holiday with its turnaround narrative as loud as ever—and just as contested. After a volatile Christmas Eve session, Intel stock last traded at $36.18 (Dec. 24 close), down 0.56% on the day, with a $172B market cap and a 52-week range spanning roughly $18.59 to $44.02. The big reason the stock is back in headlines this week: reports that Nvidia tested Intel’s advanced 18A manufacturing process but stopped moving forward, a development that lands directly on the most sensitive part of Intel’s story—whether Intel Foundry can win (and
Warner Bros. Discovery (WBD) Stock News Today: Netflix Deal, Paramount’s $30 Bid, and the Latest Analyst Forecasts (Dec. 25, 2025)

Warner Bros. Discovery (WBD) Stock News Today: Netflix Deal, Paramount’s $30 Bid, and the Latest Analyst Forecasts (Dec. 25, 2025)

Warner Bros. Discovery, Inc. (NASDAQ: WBD) stock is spending Christmas week in a very un-Christmas-like place: the middle of a full-scale M&A tug-of-war that could redraw the streaming map and reshape Hollywood’s power structure. As of the last U.S. market close on Wednesday, Dec. 24, 2025, WBD stock traded around $29.23, near the top of its 52-week range (about $7.25 to $30.33)—a dramatic swing that reflects how quickly the narrative has shifted from “media turnaround” to “deal math.” The reason is simple: Netflix has a signed deal to buy WBD’s studios-and-streaming crown jewels, while Paramount Skydance is running a hostile,
D-Wave Quantum (QBTS) Stock News Today: CES 2026 Catalyst, Analyst Forecasts, and a Reality Check on Valuation

D-Wave Quantum (QBTS) Stock News Today: CES 2026 Catalyst, Analyst Forecasts, and a Reality Check on Valuation

Published: December 25, 2025 D-Wave Quantum Inc. (NYSE: QBTS) heads into the Christmas break with the kind of chart that makes both momentum traders and risk managers reach for caffeine: a big 2025 run, a sharp December surge tied to fresh visibility at CES 2026, and then a quick pullback as the market digests insider-selling headlines and a valuation that’s sprinted far ahead of current revenue. Because U.S. markets are closed on December 25, the most recent regular-session print investors have is Wednesday, Dec. 24, when QBTS closed at $27.52, down about 5.5% on the day, after trading between roughly
Ondas Holdings (ONDS) Stock: Latest News, Analyst Forecasts, and What’s Driving the Defense-Tech Story (Dec. 25, 2025)

Ondas Holdings (ONDS) Stock: Latest News, Analyst Forecasts, and What’s Driving the Defense-Tech Story (Dec. 25, 2025)

Ondas Holdings Inc. (NASDAQ: ONDS) heads into the Christmas holiday with investors focused less on day-to-day trading (U.S. markets are closed on December 25) and more on a late‑2025 sequence of contracts, acquisitions, and defense-focused expansion moves that have reshaped the company’s narrative. In the shortened Christmas Eve session (Dec. 24, 2025), ONDS last traded around $9.07. StockAnalysis That price level matters for one simple reason: after a year of dramatic swings, Ondas is now being valued like a company the market expects to become a meaningful player in counter-drone (C‑UAS), autonomous surveillance, and multi-domain robotics—but it still has to
Disney Stock (DIS) on Dec. 25, 2025: Today’s News, Analyst Forecasts, and What Could Move Shares Next

Disney Stock (DIS) on Dec. 25, 2025: Today’s News, Analyst Forecasts, and What Could Move Shares Next

The Walt Disney Company (NYSE: DIS) heads into the Christmas holiday with its stock perched near the mid-$110s after a strong month—and with Wall Street’s attention split between Disney’s own execution (streaming profitability, parks cash flow, and capital returns) and the industry’s rapidly shifting chessboard (most notably, the Warner Bros. Discovery bidding battle). Nasdaq Disney shares last closed at $114.48 (Dec. 24), capping a roughly 9.6% gain over the past month, according to a widely circulated Zacks/Nasdaq market wrap. Nasdaq Below is a comprehensive roundup of the most current Disney stock news, forecasts, and analyst takes circulating as of 25.12.2025,
Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Bristol-Myers Squibb Company (NYSE: BMY) heads into Dec. 25, 2025 with its stock anchored in the mid-$50s — and with investors juggling two competing storylines: With U.S. markets effectively pausing for the holiday, the most recent available NYSE quote showed BMY around $54.71 (last trade timestamp recorded Dec. 24), after trading between roughly $54.20 and $54.75 intraday. Bristol Myers Squibb Investors Bristol-Myers Squibb stock price today: where BMY stands into Dec. 25, 2025 BMS’s own investor quote page showed BMY at $54.71 on Dec. 24 (delayed quote), with a prior close listed as $54.28 and a 52-week range of $42.52
Lucid Stock (LCID) Today: Latest News, Analyst Forecasts, and What’s Driving Lucid Group Shares on Dec. 25, 2025

Lucid Stock (LCID) Today: Latest News, Analyst Forecasts, and What’s Driving Lucid Group Shares on Dec. 25, 2025

Lucid Group, Inc. (NASDAQ: LCID) heads into Christmas Day with its stock still pinned near the lows that have defined much of 2025. With U.S. markets closed for the holiday, the most recent trade was $11.81 (Dec. 24), after an intraday range of $11.62–$11.845. For investors watching Lucid stock right now, the story is a three-way tug-of-war: Below is a detailed, news-forward roundup of what’s happening around Lucid stock as of Dec. 25, 2025, and what the latest forecasts and analyses are emphasizing. Lucid stock price check on Dec. 25, 2025: where LCID stands Because Christmas Day is a market
Lam Research (LRCX) Stock News Today: Record Highs, CEO Share Sale, Analyst Price Targets, and 2026 Outlook (Dec. 25, 2025)

Lam Research (LRCX) Stock News Today: Record Highs, CEO Share Sale, Analyst Price Targets, and 2026 Outlook (Dec. 25, 2025)

Lam Research Corporation (NASDAQ: LRCX) heads into Christmas Day with momentum—and a few headline-worthy crosscurrents. In the last U.S. trading session before the holiday (a shortened Christmas Eve session), LRCX closed at $177.33, marking a fresh 52‑week high as the broader market also finished at record levels. MarketWatch But the story investors are chewing on isn’t just “new high.” It’s new high + insider sale + a wave of analyst target changes + a sector narrative built around AI-driven memory demand—with real policy risk sitting in the background like a plot twist you can’t skip. Below is a full, publication-ready
1 97 98 99 100 101 282

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop